Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)
Grant Opportunity Analysis
The Department of Health and Human Services and the National Institute of Allergy and Infectious Diseases (NIAID) are seeking applications to support a Clinical Research Network (CRN) on Antimicrobial Resistance. This cooperative agreement requires the design, management, and implementation of clinical trials and studies addressing critical bacterial and fungal antimicrobial resistance threats identified by the CDC. The network will be structured into four synergistic hubs: a Scientific Leadership Center, a Clinical Operations Center, a Laboratory Center, and a Statistics and Data Coordination Center. Eligible applicants include domestic higher education institutions, nonprofits, and for-profit organizations, while foreign subawards or subcontracts are strictly prohibited. NIAID intends to commit $18 million in FY 2027 to fund one award for a seven-year project period, with applications due by November 10, 2026.
Eligible Applicants
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/Foreign CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed. NIH will no longer issue awards (i.e., new, renewal, or non-competing continuation) to domestic or foreign entities that involve foreign subawards/subcontracts. All NIH-funded research involving foreign subawards/subcontracts must be submitted in response to a NOFO that is specifically designated for funded international collaborations. See NIH Grants Policy Statement 16.8 Collaborative International Research Awards.Applications involving foreign subawards/subcontracts submitted in response to this NOFO will be deemed noncompliant and will not be considered for funding. This policy applies to all monetary international collaborations resulting in foreign subawards/subcontracts, however, it does not preclude unfunded international collaborations or foreign components, funding for foreign consultants, or procurement of unique equipment or supplies from foreign vendors.